Bios Life 2[R] (fiber/nutrient supplement). (Nutraceuticals Research).Nutraceutical: Bios Life 2 (r) (fiber/nutrient supplement) Indication: Cholesterol and homocysteine Homocysteine Definition Homocysteine is a naturally occurring amino acid found in blood plasma. High levels of homocysteine in the blood are believed to increase the chance of heart disease, stroke, Alzheimer's disease, and osteoporosis. reduction Source: J Metab September 2002;571(9):1166-70 Research: The study compared fasting blood samples from approximately 100 subjects over an eight-week period. All study participants followed the National Cholesterol Education Program The National Cholesterol Education Program is a program managed by the National Heart, Lung and Blood Institute, a division of the National Institutes of Health. Its goal is to reduce increased cardiovascular disease rates due to hypercholesterolemia (elevated cholesterol (NCEP NCEP National Cholesterol Education Program ) Step 1 diet for six weeks prior to beginning the study. Additionally, no concurrent lipid-lowering therapy or statin stat·in n. Any of a class of drugs that inhibit a key enzyme involved in the synthesis of cholesterol and promote receptor binding of LDL cholesterol, resulting in decreased levels of serum cholesterol. during the previous 30 days was permissible. Those participants who still had LDL cholesterol LDL cholesterol n. See low-density lipoprotein. LDL Cholesterol Low-density lipoprotein cholesterol is the primary cholesterol molecule. High levels of LDL increase the risk of coronary heart disease. greater than 130 mg/dl following the six week diet program were included in the study and were required to continue to follow the NCEP Step 1 diet for the duration of the investigation. Half of the study participants were given twice daily servings of Bios Life 2 and the other half were given a placebo. Neither the researchers nor the participants were aware of which substance any individual received. Results: The group receiving Bios Life 2 had a significant reduction in LDL cholesterol levels averaging 8%, while LDL LDL - ["LDL: A Logic-Based Data-Language", S. Tsur et al, Proc VLDB 1986, Kyoto Japan, Aug 1986, pp.33-41]. increased an average of 2% for the participants that received the placebo over the eight-week period, for a 10% difference between the groups. Similarly, total cholesterol levels for the Bios Life 2 group was significantly reduced by an average of 6%, while total cholesterol levels for the participants receiving the placebo rose an average of 3%. A significant reduction in blood homocysteine levels in the Bios Life 2 group was also observed. Homocysteine levels were found to drop significantly--an average of 11%--among the Bios Life 2 group, while those in the placebo group dropped an insignificant 2%. |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion